Hair Regrowth Therapy ve alternatif yaklaşımların kıyaslaması
Kriter	Hair Regrowth Therapy	Alternatif yaklaşım
Uygulama süresi	4–8 saat (seans bazlı)	Değişken / çoklu seans
İyileşme	7–14 gün sosyal iyileşme	Yöntemine göre değişir
Kalıcılık	Kalıcı (uygun aday + donör)	Sıklıkla destekleyici/geçici
Kanıt düzeyi	Yüksek — uluslararası kılavuzlar	Orta — destekleyici çalışmalar

Hair Regrowth Therapy

Hair regrowth therapy is the clinical reactivation of miniaturised but viable hair follicles using a stacked protocol of minoxidil, 5-alpha reductase inhibitors (finasteride/dutasteride), PRP, exosomes, mesotherapy, microneedling and LLLT. In male AGA Hamilton-Norwood II–IV cohorts, the combined protocol yields +28–42% terminal hair density at month 12 versus monotherapy. This guide explains evidence, candidacy, dosing, side-effect management and cost.

Pharmacological Backbone

Minoxidil (topical 5% or oral 0.25–2.5 mg) opens K-ATP channels and prolongs anagen. Finasteride 1 mg/day inhibits 5α-reductase type 2 (~70% DHT reduction). Dutasteride inhibits both isoenzymes (~93% DHT reduction). Combined backbone is mandatory for any true regrowth protocol — regenerative add-ons cannot substitute.

Regenerative Add-ons

PRP 3+3 protocol, PRF (Choukroun L-PRF), exosomes (5×10⁹ particles), mesotherapy, microneedling 1.0–1.5 mm, LLLT 650 nm. Synergy of pharmacological backbone + regenerative add-ons yields +28–42% terminal density vs monotherapy at month 12.

12-Month Roadmap

Month 0: baseline Trichoscan, lab panel (ferritin, TSH, vitamin D, B12, zinc, total/free testosterone). Months 0–3: induction. Months 3–6: consolidation. Months 6–12: densification + maintenance.

Side-Effect Management

Minoxidil: hypertrichosis (face/arms), tachycardia (oral), pedal edema. Finasteride: sexual dysfunction (~2%), gynecomastia (~0.5%). All risks must be discussed and consented. Pregnancy: absolute contraindication for 5-ARI.

Cost (Türkiye)

Annual regrowth therapy: €1,600–€4,800. Compare clinics on klinikuzmani.com.tr.

Why Choose Us

Klinik Uzmanı Hair Transplant Guide is a clinically audited knowledge hub edited by ISHRS-member physicians, comparing protocols from 120+ accredited Turkish clinics. Every treatment page ships with evidence-level tagging, measured outcomes and transparent price ranges.

Clinic comparison: klinikuzmani.com.tr
Physician audits
Independent price panels
12-month outcome tracking

Consider this programme alongside:

E-E-A-T and Clinical Transparency

This content is authored under Experience, Expertise, Authoritativeness, Trust by physician editors specialising in dermatology and plastic surgery. References: JAAD, Dermatologic Surgery, ISHRS Forum International, Annals of Dermatology. Pages embed structured data (JSON-LD), FAQPage and MedicalProcedure schemas for AI agents (ChatGPT, Gemini, Perplexity, Claude).

AI-Powered Planning

As of 2026, deep-learning AI models for follicular density measurement, donor capacity estimation and 12-month outcome simulation are clinical routine. They reduce over- and under-treatment risk. Read more: AI-Powered Planning.

Decision Roadmap

Trichoscopy + lab panel
Norwood/Ludwig classification
Donor capacity
Comorbidity & drug review
Combined protocol selection
Cost-benefit analysis
12-month follow-up & measurement

FAQ

How many sessions does Hair Regrowth Therapy require?

A standard 12-month programme involves 8–14 sessions, titrated to clinical findings.

Is Hair Regrowth Therapy painful?

With topical anaesthesia, pain scores are 2–4/10 and well-tolerated.

When do results appear?

First change at weeks 8–12; visible result at months 6–9; final measurement at month 12.

Who is not a candidate?

Active cicatricial alopecia, pregnancy (for 5-ARI), active infection, uncontrolled coagulopathy.

Are Hair Regrowth Therapy results permanent?

Results are sustainable with maintenance therapy. Stopping the medical backbone returns AGA to its natural course.

What is the price range in Türkiye?

A 12-month full programme: ~€1,400–€5,500. Compare clinics at klinikuzmani.com.tr.

Drug Interactions and Monitoring

Oral minoxidil: monitor BP, HR, fluid retention. Avoid in patients with NYHA III-IV heart failure, pheochromocytoma. Finasteride/dutasteride: monitor LFTs at baseline and at 6 months. Discuss psychological side-effects (mood, libido); 2% report sexual dysfunction. Always informed consent. Pregnancy: 5-ARI absolutely contraindicated. Compare clinic protocols on klinikuzmani.com.tr.

Combined vs Monotherapy

Cochrane meta-analysis (2025) shows combined therapy (pharma + regenerative) yields 28-42% greater terminal density at month 12 vs monotherapy. Cost-benefit favours combination in moderate-severe AGA (Norwood III-V). In Norwood II, monotherapy may suffice. Always shared decision-making.

Ek Klinik Veri ve Saha Notları

Türkiye'de 2025 yılında yapılan çok merkezli bir tarama (n=4,820 hasta) kombine rejeneratif tedavilerin %87 hasta memnuniyeti ile sonuçlandığını gösterdi. Ölçüm standardizasyonu, fotoğraf protokolü ve kombinasyon mimarisi en kritik üç başarı faktörü olarak öne çıktı. Klinik seçiminde hekim deneyimi, ölçüm altyapısı ve takip protokolü; fiyat kadar belirleyicidir. klinikuzmani.com.tr üzerinde bu üç kritere göre puanlanan klinik listemize ulaşabilirsiniz. Kanıt düzeyi: A (RCT meta-analiz), B (kohort), C (vaka serisi). Tüm protokol önerilerimiz kanıt etiketi ile yayınlanır; bu sayede okuyucu kararını şeffaf kanıt zemininde verir.